Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cells.

MLA

Levenson, A. S., et al. “Agonist Activity of Antiestrogen-Receptor Complexes to Regulate Urokinase Plasminogen Activator (UPA) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Endogenous Gene Expression in Breast Cancer Cells.” Cancer Letters, vol. 125, no. 1–2, Mar. 1998, pp. 215–20. EBSCOhost, https://doi.org/10.1016/s0304-3835(97)00516-8.

APA

Levenson, A. S., Svoboda, K. M., Kwaan, H. C., & Jordan, V. C. (1998). Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cells. Cancer Letters, 125(1–2), 215–220. https://doi.org/10.1016/s0304-3835(97)00516-8

Chicago

Levenson, A S, K M Svoboda, H C Kwaan, and V C Jordan. 1998. “Agonist Activity of Antiestrogen-Receptor Complexes to Regulate Urokinase Plasminogen Activator (UPA) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Endogenous Gene Expression in Breast Cancer Cells.” Cancer Letters 125 (1–2): 215–20. doi:10.1016/s0304-3835(97)00516-8.